These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20110726)

  • 41. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
    Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women.
    Agrawal R; Sharma S; Bekir J; Conway G; Bailey J; Balen AH; Prelevic G
    Fertil Steril; 2004 Nov; 82(5):1352-7. PubMed ID: 15533359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
    Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Female Pelvic Conditions: Polycystic Ovary Syndrome.
    Wilkinson LD; Brady PH; Gin GT; Rosenblum E
    FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations.
    Deswal R; Nanda S; Ghalaut VS; Roy PS; Dang AS
    Int J Gynaecol Obstet; 2019 Sep; 146(3):370-379. PubMed ID: 31220344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study.
    Nair MK; Pappachan P; Balakrishnan S; Leena ML; George B; Russell PS
    Indian J Pediatr; 2012 Jan; 79 Suppl 1():S69-73. PubMed ID: 21769526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.
    Hahn S; Bering van Halteren W; Roesler S; Schmidt M; Kimmig R; Tan S; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):175-81. PubMed ID: 16705549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
    Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
    Pembe AB; Abeid MS
    Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
    Li R; Zhang Q; Yang D; Li S; Lu S; Wu X; Wei Z; Song X; Wang X; Fu S; Lin J; Zhu Y; Jiang Y; Feng HL; Qiao J
    Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
    Livadas S; Pappas C; Karachalios A; Marinakis E; Tolia N; Drakou M; Kaldrymides P; Panidis D; Diamanti-Kandarakis E
    Endocrine; 2014 Nov; 47(2):631-8. PubMed ID: 24752393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
    Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
    Skiba MA; Islam RM; Bell RJ; Davis SR
    Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.
    Davis SR; Knight S; White V; Claridge C; Davis BJ; Bell R
    Gynecol Endocrinol; 2002 Dec; 16(6):443-6. PubMed ID: 12626030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.